Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.
BACKGROUND MGMT methylation status can influence the therapeutic effect and prognosis of glioblastoma (GBM). There are conflicting results from studies evaluating the efficacy of bevacizumab (BV) when it is combined with temozolomide (TMZ) and radiotherapy (RT) in patients diagnosed with GBM with different MGMT methylation status. MATERIAL AND METHODS Data were extracted from publications in PubMed, Embase, and The Cochrane Library, with the last search performed March 23, 2016. Data on overall survival (OS), progression-free survival (PFS), and MGMT methylation status were obtained. RESULTS Data from 3 clinical trials for a total of 1443 subjects were used for this meta-analysis. MGMT methylated and unmethylated patients showed improved PFS in the BV group (pooled HRs, 0.769, 95% CIs 0.604-0.978, P=0.032; 0.675, 95%CIs 0.466-0.979, P=0.038). For patients with either type of GBM, BV did not improve the OS based on the pooled HRs 1.132 (95% CIs 0.876-1.462; P=0.345) for methylated and 1.018 (95% CIs 0.879-1.179; P=0.345) for unmethylated. CONCLUSIONS Bevacizumab combined with temozolomide-radiotherapy correlated with improved PFS for treatment of patients with different MGMT methylation status of newly diagnosed GBM. There was insufficient evidence to determine the synergistic effects of combining BV with TMZ and RT on improving survival in patients with different MGMT methylation status.
Department of Neurosurgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (mainland).
Chigang
C
Du
Department of Blood Transfusion, Liaocheng People's Hospital, Liaocheng, Shandong, China (mainland).
Junquan
J
Ren
Department of Neurosurgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (mainland).
Rui
R
Zhang
Department of Neurosurgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (mainland).
Tao
T
Xin
Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng, Shandong, China (mainland).
Zhongmin
Z
Li
Department of Neurosurgery, Liaocheng People's Hospital, Liaocheng, Shandong, China (mainland).
Zhiti
Z
Zhang
Department of Gynecology and Obstetrics, Liaocheng People's Hospital, Liaocheng, Shandong, China (mainland).
Xinghua
X
Xu
Department of Neurosurgery, Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China (mainland).
Qi
Q
Pang
Lancet Oncol. 2009 May;10 (5):459-66
19269895
N Engl J Med. 2014 Feb 20;370(8):699-708
24552317
Adv Ther. 2011 Apr;28(4):334-40
21432029
Trials. 2007 Jun 07;8:16
17555582
J Neurooncol. 2015 Mar;122(1):135-43
25524817
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):670-6
19836157
Jpn J Clin Oncol. 2012 Oct;42(10):887-95
22844129
J Clin Oncol. 2009 Feb 10;27(5):740-5
19114704
J Neurooncol. 2007 May;83(1):91-3
17164975
J Neurosurg. 2012 Feb;116(2):341-5
22035272
Neuro Oncol. 2009 Feb;11(1):69-79
18772354
J Neurosurg. 2015 May;122(5):1144-50
25768833
Radiat Oncol. 2014 Jun 03;9:128
24893775
J Clin Oncol. 2013 Nov 10;31(32):4085-91
24101040
J Clin Oncol. 2007 Oct 20;25(30):4722-9
17947719
Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1372-80
18355978
Cancer. 2015 Apr 1;121(7):997-1007
25263092
N Engl J Med. 2014 Feb 20;370(8):709-22
24552318
J Neurooncol. 2016 Jan;126(1):185-92
26476729
Clin Cancer Res. 2011 Jun 15;17 (12 ):4119-24
21531816
BMJ. 2003 Sep 6;327(7414):557-60
12958120
J Clin Oncol. 2015 Sep 1;33(25):2735-44
26124478
J Clin Oncol. 2015 Apr 1;33(10):1197-213
25713439
J Clin Oncol. 2009 Oct 1;27(28):4733-40
19720927
Clin Cancer Res. 2014 Oct 1;20(19):5023-31
25107913
Stat Med. 2008 Mar 30;27(7):954-70
17676579
Neuro Oncol. 2009 Dec;11(6):842-52
19229057
Nat Rev Drug Discov. 2011 Jun;10(6):417-27
21629292
J Clin Oncol. 2011 Jan 10;29(2):142-8
21135282
Oncologist. 2015 Feb;20(2):107-8
25582142
Neuro Oncol. 2016 May;18(5):735-43
26538618
BMJ. 1997 Sep 13;315(7109):629-34
9310563
J Neurooncol. 2015 Jun;123(2):251-7
25920710
Future Oncol. 2010 Sep;6(9):1407-14
20919826
N Engl J Med. 2005 Mar 10;352(10 ):997-1003
15758010
Cancer Med. 2013 Apr;2(2):185-95
23634286
Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):58-66
21036490
Radiol Oncol. 2010 Jun;44(2):113-20
22933901
J Clin Neurosci. 2013 Jun;20(6):783-9
23639619
Eur J Epidemiol. 2010 Sep;25(9):603-5
20652370